Symbols

AIMD

Ainos·NASDAQ

--(--)

AIMD Profile

Ainos, Inc.

A healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications

Industry

Biological Technology

Established Date

06/26/1984

Listing Date

08/09/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.ainos.com

Security Type

Common stock

Office address

3050 Post Oak Blvd, Suite 510-T80 Houston, TX 77056

Business

Introduction

Ainos, Inc., a Texas corporation, was founded on June 26, 1984. Ainos is a diversified medical technology company focused on the development of novel point-of-care tests (POCT), low-dose interferon therapy and synthetic RNA (SRNA) to drive preventive medicine. Since its inception, the company has focused on research into low-dose non-injectable interferon therapies. The company recently expanded its product candidates to POCT to diversify the company's revenue streams. The POCT device is based on the core technology involved in the COVID 19 POCT product and other POCT products that detect volatile organic compounds (VOCs) released by the human body.